CGM in Philadelphia

TL;DR: A continuous glucose monitor is a small sensor you wear on your arm that shows your blood sugar all day on your phone. If you have diabetes and take insulin, it is essential. If you do not have diabetes, it is a learning tool, and 2 weeks of your own data teaches most people more than a year of general advice. Get 2 sensors rather than 1. Wear the first one and change nothing on purpose, so you find out what an ordinary week does to you, and log what you ate and how you slept in the app while it is happening instead of trying to remember later. Then make specific changes for a few weeks. Then wear the second sensor to find out whether the changes held. Buying them together on a 4-week plan costs less than buying them one at a time.

CGMs have become one of the most discussed tools in metabolic health. Some of the enthusiasm is earned: they catch dynamic glucose patterns that fasting glucose and HbA1c miss, they motivate behavior change, and they are clinically essential in insulin-using diabetes. Some of the enthusiasm is theater: the marketing of continuous lifetime CGM use to healthy adults outpaces the evidence that it changes outcomes.

This page is the middle ground: where CGMs help in Philadelphia, where they do not, and how Fishtown Medicine uses them.

What CGMs measure

CGMs measure interstitial glucose (the glucose in the fluid between cells) every 1-5 minutes via a sensor worn on the upper arm or abdomen. Sensors are typically replaced every 10-14 days. Data streams to a smartphone app, where you can see real-time glucose, daily patterns, and how specific meals affect you.

The data includes:

• Time-in-range. What percentage of the time your glucose is in a target range (typically 70-180 for diabetes, often 70-140 or tighter for non-diabetic use).
• Post-prandial peaks. How high glucose climbs after meals and how long it takes to come back down.
• Overnight patterns. Sometimes catches sleep-related hypoglycemia or dawn-phenomenon hyperglycemia.
• Glycemic variability. The standard deviation of glucose values; high variability correlates with worse metabolic outcomes.

CGMs in Philadelphia

Prescription CGMs: Dexcom G7, FreeStyle Libre 3, Medtronic systems. Available with prescription from any primary care practice. Insurance coverage is excellent for diabetes; for non-diabetic use, coverage varies.

Over-the-counter CGMs: Lingo (Abbott) and Stelo (Dexcom) are available without a prescription, designed for the non-diabetic metabolic health market. A single 30-day pack runs around $89, and the multi-sensor plans work out cheaper per sensor.

Lingo is the one we point most people toward, for a reason covered in the next section: the plan that includes 2 sensors costs less than buying 2 separately, and the way we use a CGM needs 2.

Local pharmacies (Walgreens, CVS, Rite Aid) typically stock at least one option. Mail-order pharmacy programs for diabetes-prescribed CGMs are also common.

Where CGMs help (non-diabetic use)

The highest-value non-diabetic use cases:

• Suspected insulin resistance or prediabetes with normal fasting glucose. A 2-4 week CGM window catches post-prandial peaks that standard testing misses. This includes patients at a normal BMI, since insulin resistance is common without obesity.
• PCOS or metabolic syndrome evaluation. The dynamic glucose pattern is more informative than fasting values.
• Weight-loss plateau evaluation. CGMs sometimes reveal specific foods or eating windows that are stalling progress.
• Patient motivation and behavior change. Seeing your glucose spike after specific foods often changes behavior more durably than verbal advice.
• Suspected hypoglycemia or dawn phenomenon when standard testing is inconclusive.

When CGMs are less useful:

• Asymptomatic metabolically healthy adults with normal HbA1c, normal fasting insulin, normal lipid panel, and no PCOS. Continuous data here is interesting but rarely changes clinical decisions.
• Patients with disordered eating histories. CGMs can drive restrictive behavior in some patients.
• Continuous lifetime use for healthy adults. A short diagnostic window followed by behavior change is usually sufficient.

How Fishtown Medicine uses CGMs

We use 2 sensors, one at a time, never both together. You wear the first, take it off, then go weeks with nothing on your arm before the second one goes on. The gap in between is where the value lives.

The first sensor is the learning run. You wear it through a normal 10 to 14 days without changing anything on purpose, because a week of eating the way you usually eat is the only baseline worth having. While it is on, log what you suspect in the app as it happens: the meal you think caused a spike, the night you slept badly, the day you skipped training, the dinner that ran late. Guessing in the moment and being wrong is useful. Reconstructing a week later from memory is not. There is no judgment attached to this run, and it is not a test you can fail.

Then the sensor comes off, and the work happens with nothing tracking you. We go through the first run together and pick a few changes aimed at your patterns rather than general advice, and you live with them for 2 to 6 weeks before the second sensor goes on. That gap is deliberate: without it, this turns into an exercise in watching a number instead of what it is for, which is a change to how you eat, move, and sleep that holds up on its own.

The second sensor is the check. You wear it after the new pattern has had time to become ordinary, and it answers the only question that matters: did the changes hold, and did they move the numbers. Seeing your own glucose curve flatten is more persuasive than anything a clinician can say, and when something has not moved, we find that out while it is still easy to adjust.

That structure is why we point people to Lingo's 4-week plan, which ships 2 sensors and costs less than buying them one at a time. Stelo works the same way if you prefer it. Either way, the sensor is yours to buy directly, we take no cut, and reading the data with you is part of membership.

What we look for in the data is not a single number. We watch how high glucose climbs after a meal and how long it takes to come down, how far it falls afterward, and which habits move both. Training within a day of a meal changes the response noticeably, because working muscle pulls glucose out of the blood without needing much insulin to do it, and people are often surprised how much a walk after dinner does. Sleep loss and late eating usually show up too.

Patients who benefit from longer-term monitoring (active diabetes management, weight loss with CGM motivation, complex insulin resistance) get extended use.

For diabetes management, we follow standard practice: CGM is standard of care for type 1 and insulin-using type 2 diabetes.

What it costs

Membership at Fishtown Medicine covers all visits and ongoing management; see pricing for current rates. CGM interpretation and the behavior-change conversations are inside the membership. The sensors themselves are billed separately:

• Diabetes with insurance coverage: copays typically $25-100/month.
• Non-diabetic prescription use: insurance coverage variable.
• Over-the-counter Lingo or Stelo: around $89 for a single 30-day pack, less per sensor on the 4-week plan that includes 2.

We take no referral fee on any of this, and any discount we have passes straight through to you.

Related Services and Reading

• Metabolic Health in Philadelphia

• GLP-1 Weight Loss in Philadelphia

• PCOS Care in Philadelphia

• Metabolic Health Pillar

• Direct Primary Care in Philadelphia

• Advanced Lipid Testing - ApoB, Lp(a), and the panel beyond LDL

• DEXA Scan - body composition and bone density measurement

• VO2 Max Testing - the strongest single predictor of all-cause mortality

• How to Share Your Wearable and Glucose Data - getting the numbers into your chart so they get read